Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arrestin domain-containing protein 5 (ARRDC5) is an alpha-arrestin family adapter protein involved in the regulation of protein transport and endocytosis, as well as spermatogenesis in mammals[1][3][4][5]. It is expressed in testicular germ cells, particularly during the round and elongated spermatid phases, and its loss leads to male sterility without affecting females, establishing it as an essential regulator of sperm maturation[4][5]. ARRDC5 is also implicated in osteoclast differentiation by regulating V-type ATPase localization and bone resorption activity[2]. The protein has been identified as a potential target for non-hormonal male contraception and as a possible prognostic marker in certain cancers, such as lung adenocarcinoma, although its molecular mechanism of action, especially in human disease, is not fully defined[1][3][4].
Not established in drug context. Presumed to act as an E3 ubiquitin ligase adaptor, which could be targeted by molecules modulating ubiquitination or protein transport. Inhibiting ARRDC5 could disrupt sperm maturation, leading to male contraceptive effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arrestin domain-containing protein 5 (ARRDC5).